Tyndall Capital Partners’s Traws Pharma TRAW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-1,644
| Closed | -$524K | – | 3 |
|
2019
Q3 | $524K | Sell |
1,644
-525
| -24% | -$167K | 19.34% | 2 |
|
2019
Q2 | $2.32M | Sell |
2,169
-8
| -0.4% | -$8.55K | 47.11% | 2 |
|
2019
Q1 | $2.69M | Hold |
2,177
| – | – | 53.28% | 1 |
|
2018
Q4 | $1.72M | Hold |
2,177
| – | – | 48.29% | 2 |
|
2018
Q3 | $5.99M | Hold |
2,177
| – | – | 75.56% | 1 |
|
2018
Q2 | $4.95M | Buy |
2,177
+1,804
| +484% | +$4.1M | 71.91% | 1 |
|
2018
Q1 | $1.75M | Buy |
373
+196
| +111% | +$920K | 45.59% | 2 |
|
2017
Q4 | $1.5M | Hold |
177
| – | – | 43.06% | 2 |
|
2017
Q3 | $1.71M | Hold |
177
| – | – | 21.79% | 2 |
|
2017
Q2 | $2.15M | Buy |
177
+84
| +90% | +$1.02M | 25.49% | 2 |
|
2017
Q1 | $1.58M | Hold |
93
| – | – | 45.53% | 1 |
|
2016
Q4 | $1.18M | Hold |
93
| – | – | 41.42% | 2 |
|
2016
Q3 | $1.45M | Buy |
+93
| New | +$1.45M | 78.8% | 1 |
|